Showing results (31-40 of 250) with videos related to
Sort By:
Pageof 25
Seminars in Oncology|August 9, 2005
A comparative review of classification systems in myelodysplastic syndromes (MDS)John M BennettClinical Lymphoma, Myeloma & Leukemia|October 4, 2016
Changes in the Updated 2016: WHO Classification of the Myelodysplastic Syndromes and Related Myeloid NeoplasmsJohn M BennettAmerican Journal of Hematology|September 4, 2008
Consensus statement on iron overload in myelodysplastic syndromesJohn M Bennett, Leukemia & Lymphoma|April 4, 2013
The myelodysplastic syndromes: a personal recollection of four decades of classification and prognostic scoring systemsJohn M BennettJournal of Clinical Pathology|November 28, 2019
Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndromeIbraahim Badaat, Sabbir Mirza, Eric Padron, et al.Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Immunosuppressive Therapy: Exploring an Underutilized Treatment Option for Myelodysplastic SyndromeMintallah Haider, Najla Al Ali, Eric Padron, et al.American Journal of Hematology|March 25, 2015
WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptidesJason Brayer, Jeffrey E Lancet, John Powers, et al.Blood Advances|September 21, 2022
U2AF1 and EZH2 mutations are associated with nonimmune hemolytic anemia in myelodysplastic syndromesRami Komrokji, Luis E Aguirre, Najla Al Ali, et al.Journal of Vascular and Interventional Radiology : JVIR|September 1, 2019
Partial Splenic Artery Embolization in 35 Cancer Patients: Results of a Single Institution Retrospective StudyBela Kis, Matthew Mills, Johnna Smith, et al.Blood Cancer Journal|November 15, 2022
Evaluating complete remission with partial hematologic recovery (CRh) as a response criterion in myelodysplastic syndromes (MDS)Andrew M Brunner, Alexander Gavralidis, Najla Al Ali, et al.Pageof 25